These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1251 related articles for article (PubMed ID: 31838802)

  • 21. Prevention and control of seasonal influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices--United States, 2013-2014.
    Centers for Disease Control and Prevention (CDC)
    MMWR Recomm Rep; 2013 Sep; 62(RR-07):1-43. PubMed ID: 24048214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2019-20 Influenza Season.
    Grohskopf LA; Alyanak E; Broder KR; Walter EB; Fry AM; Jernigan DB
    MMWR Recomm Rep; 2019 Aug; 68(3):1-21. PubMed ID: 31441906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009.
    Fiore AE; Shay DK; Broder K; Iskander JK; Uyeki TM; Mootrey G; Bresee JS; Cox NJ;
    MMWR Recomm Rep; 2009 Jul; 58(RR-8):1-52. PubMed ID: 19644442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009.
    ;
    MMWR Recomm Rep; 2009 Aug; 58(RR-10):1-8. PubMed ID: 19713882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Seasonal influenza vaccines.
    Fiore AE; Bridges CB; Cox NJ
    Curr Top Microbiol Immunol; 2009; 333():43-82. PubMed ID: 19768400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recommendations for Prevention and Control of Influenza in Children, 2018-2019.
    COMMITTEE ON INFECTIOUS DISEASES
    Pediatrics; 2018 Oct; 142(4):. PubMed ID: 30177511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008.
    Fiore AE; Shay DK; Broder K; Iskander JK; Uyeki TM; Mootrey G; Bresee JS; Cox NS; ;
    MMWR Recomm Rep; 2008 Aug; 57(RR-7):1-60. PubMed ID: 18685555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surveillance of influenza vaccination coverage--United States, 2007-08 through 2011-12 influenza seasons.
    Lu PJ; Santibanez TA; Williams WW; Zhang J; Ding H; Bryan L; O'Halloran A; Greby SM; Bridges CB; Graitcer SB; Kennedy ED; Lindley MC; Ahluwalia IB; LaVail K; Pabst LJ; Harris L; Vogt T; Town M; Singleton JA;
    MMWR Surveill Summ; 2013 Oct; 62(4):1-28. PubMed ID: 24157710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influenza vaccination in the Americas: Progress and challenges after the 2009 A(H1N1) influenza pandemic.
    Ropero-Álvarez AM; El Omeiri N; Kurtis HJ; Danovaro-Holliday MC; Ruiz-Matus C
    Hum Vaccin Immunother; 2016 Aug; 12(8):2206-2214. PubMed ID: 27196006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness of seasonal quadrivalent versus trivalent influenza vaccination in the United States: A dynamic transmission modeling approach.
    Brogan AJ; Talbird SE; Davis AE; Thommes EW; Meier G
    Hum Vaccin Immunother; 2017 Mar; 13(3):533-542. PubMed ID: 27780425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety Profile of GSK's Inactivated Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany and Spain: Passive Enhanced Safety Surveillance Study for the 2019/2020 Influenza Season.
    Salamanca de la Cueva I; Cinconze E; Eckermann T; Nwoji U; Godderis L; Lu E; Martínez-Gómez X; Wang H; Yanni E
    Drug Saf; 2021 Dec; 44(12):1375-1390. PubMed ID: 34694589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acceptability, cost-effectiveness, and capacity of a facility-based seasonal influenza vaccination among high-risk groups: a study protocol in selected tertiary care hospitals of Bangladesh.
    Hassan MZ; Biswas MAAJ; Rahman M; Shoshi HR; Pyash AS; Islam MA; Haque MA; Parvin SR; Hossen MT; Hussain M; Rahman M; Shirin T; Chowdhury F
    BMC Public Health; 2024 Jan; 24(1):242. PubMed ID: 38245668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy, immunogenicity, and safety evaluation of an MF59-adjuvanted quadrivalent influenza virus vaccine compared with non-adjuvanted influenza vaccine in children: a multicentre, randomised controlled, observer-blinded, phase 3 trial.
    Vesikari T; Kirstein J; Devota Go G; Leav B; Ruzycky ME; Isakov L; de Bruijn M; Oberye J; Heijnen E
    Lancet Respir Med; 2018 May; 6(5):345-356. PubMed ID: 29631857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Vaccination against influenza in pregnant women - safety and effectiveness].
    Nitsch-Osuch A; Woźniak Kosek A; Brydak LB
    Ginekol Pol; 2013 Jan; 84(1):56-61. PubMed ID: 23488311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccine effectiveness of live attenuated and trivalent inactivated influenza vaccination in 2010/11 to 2015/16: the SIVE II record linkage study.
    Simpson CR; Lone NI; Kavanagh K; Englishby T; Robertson C; McMenamin J; Wissman BV; Vasileiou E; Butler CC; Ritchie LD; Gunson R; Schwarze J; Sheikh A
    Health Technol Assess; 2020 Dec; 24(67):1-66. PubMed ID: 33256892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.
    Drugs R D; 2003; 4(5):312-9. PubMed ID: 12952502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of inactivated trivalent influenza vaccine in rural India: a 3-year cluster-randomised controlled trial.
    Sullender WM; Fowler KB; Gupta V; Krishnan A; Ram Purakayastha D; Srungaram Vln R; Lafond KE; Saha S; Palomeque FS; Gargiullo P; Jain S; Lal R; Widdowson MA; Broor S
    Lancet Glob Health; 2019 Jul; 7(7):e940-e950. PubMed ID: 31200893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
    Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of influenza: recommendations for influenza immunization of children, 2007-2008.
    American Academy of Pediatrics Committee on Infectious Diseases
    Pediatrics; 2008 Apr; 121(4):e1016-31. PubMed ID: 18381500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influenza Vaccine Effectiveness for Fully and Partially Vaccinated Children 6 Months to 8 Years Old During 2011-2012 and 2012-2013: The Importance of Two Priming Doses.
    Thompson MG; Clippard J; Petrie JG; Jackson ML; McLean HQ; Gaglani M; Reis EC; Flannery B; Monto AS; Jackson L; Belongia EA; Murthy K; Zimmerman RK; Thaker S; Fry AM
    Pediatr Infect Dis J; 2016 Mar; 35(3):299-308. PubMed ID: 26658375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 63.